Any current/future new fundraising through debt or equity?

The company did not explicitly mention any current or planned fundraising through debt or equity in the provided transcript. Management emphasized a strong cash position ($322.4 million net cash and cash equivalents) and prudent capital allocation. They are actively looking for inorganic growth opportunities (M&A) but are cautious and focused on strategic acquisitions that create long-term shareholder value, not simply buying revenues. Cash held belongs to shareholders, and the company balances between shareholder returns (dividends) and keeping cash for growth or acquisitions. No specific pla

Any current/future capex/capital investment/strategic investment?

Zensar Technologies is actively investing in AI, including establishing AI labs and leveraging their agentic AI platform, ZenseAI, to deliver value to clients. They continue to invest in AI and sales to fuel growth, with some margin expansions being reinvested into these areas. The company is pursuing strategic acquisitions (inorganic growth) cautiously, aiming for long-term shareholder value rather than arbitrarily buying revenues. Cash holdings are strong, with the management balancing between distributing dividends and retaining cash for growth and acquisitions. No specific guidance on capi

Future growth expectations in sales/revenue/volumes?

Management aims to deliver double-digit profit growth going forward and is committed to this target (Page 14). Revenue growth is more uncertain; current growth is modest (1.3% YoY), below industry growth (Page 13). Management prioritizes profit growth and shareholder value over solely revenue growth (Page 10, 13). Mid-to-high single-digit revenue growth is a possible target for FY '27 but not guaranteed (Page 13). Growth in volumes (particularly offshore volume growth) is seen as a precursor to revenue growth (Page 6). The focus is on sustainable growth via a mix of organic efforts and strateg

Future growth expectations in earnings/operating earnings/profits/EPS?

Management targets consistent double-digit profit growth going forward, as confirmed by Manish Tandon. EPS growth was 24.1% year-over-year; profit growth was 18.2% year-over-year in dollar terms. Focus remains on delivering shareholder value through profit and EPS growth rather than just revenue growth. Margin expansion includes structural improvements and one-off benefits; some gains will be reinvested in AI and sales. Mid-teens EBITDA margin guidance is maintained, with continued investments. Organic growth is supplemented by a cautious but active search for strategic inorganic acquisitions.

Current/ Expected Orderbook/ Pending Orders?

The order book for the quarter stood at $180.2 million (Page 4). The average order book over the last 4 quarters has been around $180 million (Page 13). Book-to-bill ratio for the quarter is 1.12, indicating order bookings are at 1.12 times the quarterly revenue (Page 4, Page 13). Order book numbers have remained in a similar range over the recent quarters, e.g., $158.7 million last quarter, $172 million prior (Page 13). The company is comfortable with order bookings ranging between 0.9x to 1.2x quarterly revenues (Page 12). The pipeline for future orders is strong, but exact pipeline details

IN US

Sale is live|00:00:00left today

Zensar Technologies LtdQ4 FY27IT - Software

Zensar Technologies Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹445P/E: 14.7Market Cap: ₹11.7K CrSector: IT - Software

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 4

→Management aims to deliver double-digit profit growth going forward and is committed to this target (Page 14).
→Revenue growth is more uncertain; current growth is modest (1.3% YoY), below industry growth (Page 13).
→Management prioritizes profit growth and shareholder value over solely revenue growth (Page 10, 13).
→Mid-to-high single-digit revenue growth is a possible target for FY '27 but not guaranteed (Page 13).
→Growth in volumes (particularly offshore volume growth) is seen as a precursor to revenue growth (Page 6).
→The focus is on sustainable growth via a mix of organic efforts and strategic inorganic acquisitions, not just buying revenue arbitrarily (Page 14).
→Pipeline remains strong, supporting future deal wins, although conversion timing remains a focus (Page 12).
→Some headwinds from specific verticals like Healthcare and Lifesciences due to vendor consolidation but overall manageable (Page 14).

Margin guidance

Category 3

→Management targets consistent double-digit profit growth going forward, as confirmed by Manish Tandon.
→EPS growth was 24.1% year-over-year; profit growth was 18.2% year-over-year in dollar terms.
→Focus remains on delivering shareholder value through profit and EPS growth rather than just revenue growth.
→Margin expansion includes structural improvements and one-off benefits; some gains will be reinvested in AI and sales.
→Mid-teens EBITDA margin guidance is maintained, with continued investments.
→Organic growth is supplemented by a cautious but active search for strategic inorganic acquisitions.
→Management acknowledges growth challenges but is confident in turning around revenue growth to mid-to-high single digits in FY '27.
→Overall, emphasis is on sustainable profit and EPS growth, alongside strategic growth initiatives.

3 more insights locked — sign up free to unlock

Fundraise plans

→The company did not explicitly mention any current or planned fundraising through debt or equity in the provided transcript.
→Management emphasized a strong cash position ($322.4 million net cash and cash equivalents) and prudent capital allocation.
→They are actively looking for inorganic growth opportunities (M&A) but are cautious and focused on strategic acquisitions that create long-term shareholder value, not simply buying revenues.
→Cash held belongs to shareholders, and the company balances between shareholder returns (dividends) and keeping cash for growth or acquisitions.
→No specific plans were disclosed for raising new debt or equity to fund these activities.

Order book

Yes

→The order book for the quarter stood at $180.2 million (Page 4).
→The average order book over the last 4 quarters has been around $180 million (Page 13).
→Book-to-bill ratio for the quarter is 1.12, indicating order bookings are at 1.12 times the quarterly revenue (Page 4, Page 13).
→Order book numbers have remained in a similar range over the recent quarters, e.g., $158.7 million last quarter, $172 million prior (Page 13).
→The company is comfortable with order bookings ranging between 0.9x to 1.2x quarterly revenues (Page 12).
→The pipeline for future orders is strong, but exact pipeline details are not disclosed (Page 12).

Capex plans

Yes

→Zensar Technologies is actively investing in AI, including establishing AI labs and leveraging their agentic AI platform, ZenseAI, to deliver value to clients.
→They continue to invest in AI and sales to fuel growth, with some margin expansions being reinvested into these areas.
→The company is pursuing strategic acquisitions (inorganic growth) cautiously, aiming for long-term shareholder value rather than arbitrarily buying revenues.
→Cash holdings are strong, with the management balancing between distributing dividends and retaining cash for growth and acquisitions.
→No specific guidance on capital expenditure figures was provided, but emphasis is on strategic, margin-accretive investments.
→Overall, focus is on structural changes and positioning the company for better future opportunities through technology and targeted M&A.

How does Zensar Technologies Ltd rank vs peers in IT - Software?

Pro feature

1Zensar Technologies Ltd

Rev 4Mar 3

See full IT - Software sector rankings

Want more stocks like Zensar Technologies Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio